This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Discussing Biohaven's BHV-7000 for treating seizures

Ticker(s): BHVN

Who's the expert?

A neurologist with experience in treating seizures.

Interview Questions
Q1.

Could you please explain the mechanism of action of BHV-7000 in treating seizures?

Added By: slingshot_insights
Q2.

What is the efficacy of BHV-7000 in controlling seizures in patients?

Added By: slingshot_insights
Q3.

How does BHV-7000 compare to other treatments for seizures currently on the market, in terms of safety and efficacy?

Added By: slingshot_insights
Q4.

How does BHV-7000 fit into the overall treatment plan for patients with seizures?

Added By: slingshot_insights
Q5.

How has the development of BHV-7000 progressed over time, and what milestones have been achieved so far?

Added By: slingshot_insights
Q6.

Could BHV-7000 be used as a long-term treatment option for patients with chronic seizures?

Added By: slingshot_insights
Q7.

What types of seizures is BHV-7000 effective in treating?

Added By: slingshot_insights

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.